Dynamk Capital

We work with pharma and biotech companies to accelerate start-ups in Life Sciences, providing critical technologies/services for vaccines and other therapeutics

[Vernal Biosciences @vernalbio]

A randomized #clinicaltrial found that the simultaneous administration of #mRNA COVID-19 and inactivated influenza vaccines 💉 has similar safety and reactogenicity compared to sequential administration. Read the study 📘: https://t.co/EyeSikxoaV

[Alpenglow Biosciences ® @alpenglowbio]

ZEISS and Alpenglow Biosciences today announced a new partnership to jointly develop an inverted light-sheet microscope and bioinformatics pipeline tailored specifically for clinical applications. Read the Full Press Release: https://t.co/991cCIkE7I

[BioInformant @StemCellMarket]

Curi Bio and Cook MyoSite Announce Strategic Partnership - https://t.co/i5E3rOI6PY
@Curi_Bio @CookMyosite

[BioInformant @StemCellMarket]

RoosterBio Announces Collaboration with Thermo Fisher Scientific to Advance Cell and Exosome Therapy Manufacturing - https://t.co/h5ziP53KeU
@RoosterBio @thermofisher

[RoosterBio @RoosterBio]

📗 A study led by @uchicago_obgyn professor Dr. Ayman Al Hendy and colleagues recently explored ex vivo #exosome therapy models to pursue a novel, potentially safer alternative to hormone replacement therapy (HRT) for managing perimenopausal symptoms.
https://t.co/zOfTs1cRTl

[RoosterBio @RoosterBio]

RoosterBio is proud to announce that Nikon CeLL innovation Co., Ltd. (NCLi), a subsidiary of @NikonUSA Corporation, has entered into a strategic licensing agreement with RoosterBio. Read the full press release here.⤵️ https://t.co/7f4bnbjNNW

[Dynamk Capital @DynamkVC]

🧫 Exciting news from the @FDA 👏 as they launch a groundbreaking initiative to phase out animal testing for drugs. This expedites patient access to vital medications, contributes to cost savings in R&D, and is a "major step towards ending the use of laboratory animals in drug testing." Proud to be invested in @Curi_Bio supporting pharma and biotech #3Dtissues #tissueengineering #drugdiscovery #drugdevelopment

[RoosterBio @RoosterBio]

RoosterBio cells, media, and bioprocess tools are helping power clinical trials in human patients. This blog highlights 2 researchers who used RoosterBio products to rapidly launch first-in-human studies for eye disease and post-COVID lung fibrosis.⤵️
https://t.co/eFL1bavUBH

[Dynamk Capital @DynamkVC]

@Curi_Bio Bravo @Curi_Bio team!!! Proud to be supporting your efforts to advance pharma and biotech discovery and preclinical R&D.

[Curi Bio @Curi_Bio]

Curi Bio is excited to announce the grand opening of our new global headquarters in Seattle! The state-of-the-art facility expands our capacity to unlock critical functional human data that informs biopharmaceutical R&D decision-making.
Read More: https://t.co/qjXlCOx23o

[Vernal Biosciences @vernalbio]

Vernal Biosciences on LinkedIn: #gmp #therapeutics #mrna #gmpmanufacturing #cdmo https://t.co/BUzh4OB2uc

[Vernal Biosciences @vernalbio]

Vernal Biosciences on LinkedIn: #mrna #mrnadevelopment #mrna #biotech #innovation #efficiency… https://t.co/aAqhLBYwLD

[Dynamk Capital @DynamkVC]

So grateful for the important work Dynamk Capital does every day, and to be able to work in this industry together with this amazing team. Thank you to our investors, portfolio companies, advisors and many partners and supporters who have made this possi…https://t.co/rAsWvQniGA

[Dynamk Capital @DynamkVC]

It is an absolute honor to be recognized by FierceBiotech as one of 2022’s Fiercest Women in Life Sciences!

It is humbling to share my story along with the incredible and inspiring women in this list, both current and future. I want to thank all the co…https://t.co/844kWNSmzs

[Dynamk Capital @DynamkVC]

Annual General Meeting is live! Thank you to the entire team working to produce this event.

Big thanks to Jessica Davis, Sebastien Latapie, the teams at That's Nice and Launch Grow Pivot for making this a successful event! 👏🏼 https://t.co/BwIzeZ6dSB

[Dynamk Capital @DynamkVC]

I was honored today to have been among a small group of invited participants at the White House listening session focused on creating a more robust US Supply Chain for Biomanufacturing and Biotechnology innovations. This was my second time participating…https://t.co/BTNTESrwM7

[Dynamk Capital @DynamkVC]

I was honored today to have been among a small group of invited participants at the White House listening session focused on creating a more robust US Supply Chain for Biomanufacturing and Biotechnology innovations. This was my second time participating…https://t.co/LtCqL0WEBe

[Dynamk Capital @DynamkVC]

Congratulations to all the winners and nominees of last night's The Galien Foundation Gala! Dynamk Capital was honored to be a #PrixGalien nominee in the category of Incubators, Accelerators & Equity. This recognition is an incredible honor and source o…https://t.co/sS0PCPRQNQ

[Dynamk Capital @DynamkVC]

What a week in Life Sciences and in NYC!
Started with a great panel and an impressive field of investors at The Galien Foundation’s Incubator, Accelerator & Equity firm Nominees…
Closed out the day at the Springboard Enterprises Gala, meeting incredible…https://t.co/vwPdMNnST3

[Dynamk Capital @DynamkVC]

Annual General Meeting season in high gear with a few of our portfolio companies at our midtown Manhattan offices! Excited to welcome and have the participation of Florian Schuster, Co-Founder/Chief Corporate Officer at https://t.co/e4jOLyLDDL and Trond…https://t.co/dVtqV0Yksj